COVID-19 Pandemic - The government presents its daily update
QUÉBEC CITY, June 23, 2021 /CNW Telbec/ - The most recent data on the evolution of COVID-19, in the last 24 hours, in Québec show:
127 new cases, bringing the total number of people infected to 374,222;
361,840 people have recovered;
3 new deaths, for a total of 11,198 deaths:
0 deaths in the last 24 hours,
3 deaths between June 16 and June 21,
161 hospitalizations, which remains stable compared to the previous day;
40 people in intensive care, which remains stable compared to the previous day;
22,162 samples conducted on June 21.
Vaccination
100,106 doses administered are added, that is 97,047 doses in the last 24 hours and 3,059 doses before June 22, for a total of 7,572,965 doses administered in Québec. Outside Québec, a total of 19,613 doses were administered, for a cumulative total of 7,592,578 doses received by Quebecers.
8,803,035 doses received in total.
518,000 doses of Moderna were delivered yesterday.
Here are the vaccine doses still expected this week:
546,990 doses of Pfizer;
976,920 doses of Moderna.
Summary Data Evolution Table1
Date
Confirmed cases
Deaths2
Hospitalizations
Hospitalizations in intensive care
Tests performed
Administered doses of vaccine3
June 16
161
2
178 (-14)
41 (-4)
22,677
98,068
June 17
127
2
175 (-3)
39 (-2)
19,619
102,259
June 18
160
0
178 (+3)
39
17,300
91,351
June 19
103
2
170 (-8)
39
16,307
72,067
June 20
90
2
168 (-2)
39
16,367
57,381
June 21
84
2
161 (-7)
40 (+1)
22,162
84,659
June 22
127
0
161
40
NA
97,047
1 Note that the majority of data are presented according to the day they were entered. They are extracted at 4 p.m. at the date shown and cover the preceding 24 hours. However, the availability of the data on samples involves an additional delay of 24 hours and these correspond to the number of samples taken on the date shown.
2 It should also be noted that the data prior to those of the last 24 hours presented in the column Deaths have been adjusted according to the actual dates of death. This explains the variation of some data compared to those presented in previous press releases. The daily death toll is influenced by the time required for the physician to report the death, the time required to complete the investigation to confirm that the death was attributable to COVID-19, and the entry into the system.
3 Note that the number of doses administered may be subject to daily readjustment for the previous days, due to catching up due to a delay in data entry.
A reminder concerning public health instructions:
To limit the spread of the coronavirus as much as possible, it is important to follow basic preventive measures such as hand washing, physical distancing, wearing a face covering and following the instructions in effect in your region.
Remember that in the event of symptoms, it is always essential to isolate yourself and consult one of the self-care guides or call 1-877-644-4545 (or the telephone code corresponding to the region concerned) to find out the measures to be taken.
Orchid, a reproductive technology company offering the world's only commercially available whole genome embryo screening, today announced Dr. Amber Cooper, Dr. Roohi Jeelani, and Jerry Lanchbury, Ph.D as new members joining their Medical and...
Cannabix Technologies Inc. (the "Company or Cannabix") developer of alcohol and marijuana breathalyzer screening devices for law enforcement and the workplace reports that Friedel, LLC ("Friedel Clinic") a private monitoring agency, based in...
Wheel, the virtual care platform powering the future of care, today announced a strategic partnership with Owlet, Inc. ("Owlet") , the pioneer of smart infant monitoring. As part of this direct-to-consumer virtual offering, Wheel clinicians will...
The AKC Canine Health Foundation (CHF), a nonprofit organization dedicated to advancing the health of all dogs and their owners, announces that Purina has donated $111,910 in support of CHF-funded canine health research thanks to its Purina Parent...
eRSP, a trailblazer in innovative home health solutions, proudly reveals a new brand alongside a refreshed website. This step showcases eRSP's commitment to transformation, innovation and lays the groundwork for what the home health industry can...
Vistagen , a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today announced positive results from a Phase 2A pilot study of PH15, an...